ADCT · ADC Therapeutics SA · Documents
$1.52
+0.08 (+5.56%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$190.22M
Shares
127.67M
Volume · Oct 20
1.06M
Avg daily vol (3M)
1.52M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2022-11-01 | — | |
| 6-K | — | 2022-10-31 | — | |
| 6-K | — | 2022-09-22 | 2022-09-21 | |
| 6-K | — | 2022-09-16 | — | |
| 6-K | — | 2022-09-07 | — | |
| F-3 | — | 2022-09-06 | — | |
| F-3 | — | 2022-09-06 | — | |
| 6-K | — | 2022-08-15 | — | |
| 6-K | — | 2022-08-09 | 2022-06-30 | |
| 6-K | — | 2022-08-02 | — | |
| 6-K | — | 2022-07-27 | — | |
| 6-K | — | 2022-07-20 | — | |
| 6-K | — | 2022-07-11 | — | |
| 6-K | — | 2022-07-11 | — | |
| 6-K | — | 2022-06-30 | — | |
| 6-K | — | 2022-06-29 | — | |
| 6-K | — | 2022-06-13 | — | |
| 6-K | — | 2022-06-10 | — | |
| 6-K | — | 2022-06-01 | — | |
| 6-K | — | 2022-05-20 | — | |
| 6-K | — | 2022-05-12 | — | |
| 6-K | — | 2022-05-09 | — | |
| 6-K | — | 2022-05-09 | 2022-03-31 | |
| 6-K | — | 2022-05-04 | — | |
| 6-K | — | 2022-05-03 | — | |
| 6-K | — | 2022-04-04 | — | |
| 6-K | — | 2022-03-17 | 2021-12-31 | |
| 20-F | — | 2022-03-17 | 2021-12-31 | |
| 6-K | — | 2022-03-17 | — | |
| 6-K | — | 2022-03-03 | — | |
| 6-K | — | 2022-03-03 | — | |
| 6-K | — | 2022-03-01 | — | |
| 6-K | — | 2022-02-24 | — | |
| 6-K | — | 2022-02-17 | — | |
| 6-K | — | 2022-02-08 | — | |
| 6-K | — | 2022-02-02 | — | |
| 6-K | — | 2022-01-20 | — | |
| 6-K | — | 2022-01-18 | 2021-01-18 | |
| 6-K | — | 2021-11-09 | — | |
| 6-K | — | 2021-11-04 | — | |
| 6-K | — | 2021-11-02 | 2021-09-30 | |
| 6-K | — | 2021-10-29 | — | |
| 6-K | — | 2021-10-27 | — | |
| 6-K | — | 2021-09-29 | — | |
| 6-K | — | 2021-09-27 | — | |
| 6-K | — | 2021-09-23 | — | |
| 6-K | — | 2021-09-13 | — | |
| 6-K | — | 2021-09-09 | — | |
| 6-K | — | 2021-09-03 | — | |
| 6-K | — | 2021-08-26 | 2021-08-25 |
Showing 101–150 of 212 filings
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
10 filings
10 filers
Visit website
Investor relations